中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
金属研究所 [2]
上海药物研究所 [2]
采集方式
OAI收割 [4]
内容类型
期刊论文 [4]
发表日期
2018 [1]
2017 [3]
学科主题
筛选
浏览/检索结果:
共4条,第1-4条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
题名升序
题名降序
提交时间升序
提交时间降序
作者升序
作者降序
发表日期升序
发表日期降序
Discovery of novel 2,4-diarylaminopyrimidine derivatives as potent and selective epidermal growth factor receptor (EGFR) inhibitors against L858R/T790M resistance mutation
期刊论文
OAI收割
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 152, 页码: 298-306
作者:
Yan, Qi
;
Chen, Yuzhe
;
Tang, Baiyou
;
Xiao, Qiang
;
Qu, Rong
  |  
收藏
  |  
浏览/下载:86/0
  |  
提交时间:2019/01/08
EGFR inhibitors
Pyrimidine derivatives
Mutant selective inhibitors
AZD9291
T790M
A structure-guided optimization of pyrido[2,3-d]pyrimidin-7-ones as selective inhibitors of EGFR(L858R/T790M) mutant with improved pharmacokinetic properties
期刊论文
OAI收割
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 卷号: 126, 页码: 1107-1117
作者:
Yu, Lei
;
Huang, Minhao
;
Xu, Tianfeng
;
Tong, Linjiang
;
Yan, Xiao-e
  |  
收藏
  |  
浏览/下载:41/0
  |  
提交时间:2019/01/08
EGFR(T790M) mutant
Pyrido[2,3-d]pyrimidin-7-ones
Pharmacokinetic property
NSCLC
Irreversible inhibitor
Identification of hydrazone moiety-bearing aminopyrimidines as potent antitumor agents with selective inhibition of gefitinib-resistant H1975 cancer cells
期刊论文
OAI收割
CHINESE CHEMICAL LETTERS, 2017, 卷号: 28, 期号: 5, 页码: 991-994
作者:
Qin MingZe
;
Wang Lei
;
Yan Shuang
;
Ma JunJie
;
Tian Ye
  |  
收藏
  |  
浏览/下载:49/0
  |  
提交时间:2021/02/02
TYROSINE KINASE INHIBITOR
LUNG-CANCER
RECEPTOR
T790M
MUTANT
MUTATION
Aminopyrimidines
EGFR T790M/L858R
Selectivity
Anti-resistance
Antiproliferative activity
Identification of hydrazone moiety-bearing aminopyrimidines as potent antitumor agents with selective inhibition of gefitinib-resistant H1975 cancer cells
期刊论文
OAI收割
CHINESE CHEMICAL LETTERS, 2017, 卷号: 28, 期号: 5, 页码: 991-994
作者:
Qin MingZe
;
Wang Lei
  |  
收藏
  |  
浏览/下载:52/0
  |  
提交时间:2021/02/02
TYROSINE KINASE INHIBITOR
LUNG-CANCER
RECEPTOR
T790M
MUTANT
MUTATION
Aminopyrimidines
EGFR T790M/L858R
Selectivity
Anti-resistance
Antiproliferative activity